INAB
IN8bio Inc

1,801
Mkt Cap
$8.2M
Volume
13,447.00
52W High
$12.53
52W Low
$1.53
PE Ratio
-0.27
INAB Fundamentals
Price
$1.77
Prev Close
$1.77
Open
$1.76
50D MA
$1.94
Beta
0.94
Avg. Volume
73,789.42
EPS (Annual)
-$17.05
P/B
0.62
Rev/Employee
$0.00
Loading...
Loading...
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
18

Frequently Asked Questions

What is Market Cap of IN8bio Inc?
What is the 52-week high for IN8bio Inc?
What is the 52-week low for IN8bio Inc?
What is IN8bio Inc stock price today?
What was IN8bio Inc stock price yesterday?
What is the PE ratio of IN8bio Inc?
What is the Price-to-Book ratio of IN8bio Inc?
What is the 50-day moving average of IN8bio Inc?
How many employess does IN8bio Inc has?

Latest INAB News

View
No INAB news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.